All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-0925
Request that the FDA amend the prescription status of triptan medications to allow their availability as over-the-counter (OTC) products for the acute treatment of migraine headaches with or without aura in adults who have a previous diagnosis of migrainie
Documents
39
Comments
56
Description
OPEN
Key Dates
Comment Period OpensJan 30, 2026
Documents
| Type | Title | Status |
|---|---|---|
Supporting Material |
Comment Statistics
Total Comments
56
Keywords
CDER
Citizen Petition
amend the prescription status of
triptan medications to allow their
availability as over-the-counter (OTC) products
for the acute treatment of migraine headaches
with or without aura in adults who have a
previous diagnosis of migrainie
Data from Regulations.gov